Skip to main content
. Author manuscript; available in PMC: 2009 Nov 12.
Published in final edited form as: Cancer Genet Cytogenet. 2009 Aug;193(1):9–18. doi: 10.1016/j.cancergencyto.2009.03.005

Table 2.

The 20 most frequent recurring copy number aberrations in childhood leukemia, as detected by molecular inversion probes

Lineage-specific cases, %

Cases, no. Typea Chr Location Ref.b Length bp B-ALL (n = 23) T-ALL (n = 6) AML (n = 14) Genes in regionc
23 Loss 16 16q22.3 10352 44 83 50 MLKL
Gain 16 16q22.3 4 MLKL
22 Loss 10 10q25.2 2490 57 67 36 ADRA2A
19 Loss 7 7q21.13 1363 35 67 43 FZD1
Gain 7 7q21.13 4 FZD1
19 Loss 17 17p13.1 [10] 1978 17 17 36 none known
Gain 17 17p13.1 26 17 14 none known
17 Loss 14 14q24.2 [10] 270 30 50 36 none known
Gain 14 14q24.2 9 none known
16 Loss 4 4p16.3 79037 9 14 TACC3
Gain 4 4p16.3 26 33 29 TACC3
15 Loss 21 21q22.11 [11] 7219 4 7 OLIG2
Gain 21 21q22.11 30 17 36 OLIG2
15 Loss 5 5q35.3 18679 17 67 50 CLK4
15 Loss 1 1p36.12 203480 44 50 14 EIF4G3, HP1BP3, SH2D5, KIF17, DDOST
14 Loss 6 6p22.1 717 9 7 none known
Gain 6 6p22.1 26 17 29 none known
14 Loss 9 9p21.3 [10,11] 24424 35 100 CDKN2A
13 Loss 11 11q13.2 3454 22 33 36 none known
Gain 11 11q13.2 4 none known
13 Gain 2 2q31.1 12837 30 33 29 HOXD13
12 Loss 2 2q35 2774 9 17 36 FEV
Gain 2 2q35 4 17 14 FEV
12 Loss 1 1p35.1 25184 4 17 7 MARCKSL1
Gain 1 1p35.1 22 17 21 MARCKSL1
13 Loss 8 8p12~p11.2 938 17 33 7 ADRB3
Gain 8 8p12~p11.2 13 21 ADRB3
13 Loss 14 14q32.32.32.33 1223220 4 14 >5 genes
Gain 14 14q32.32~32.33 26 17 21 >5 genes
12 Gain 21 21q22.2 [10] 423958 48 17 ETS2, FLJ45139, PSMG1d
11 Loss 14 14q11.2 280777 17 50 none known
Gain 14 14q11.2 9 14 none known
11 Loss 17 17q12 29229 9 17 21 MLLT6
Gain 17 17q12 13 14 MLLT6

Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Chr, chromosome; CNA, copy number aberration; Ref., references.

a

Loss is defined as copy number ≤ 1.2. Gain is defined as copy number ≥ 2.8.

b

References: Mullighan et al., 2007 [10]; Kuiper et al., 2007 [11].

c

Based on > 1,000 genes involved in cancer development: oncogenes, tumor suppressors, DNA repair genes, cell growth genes, and metabolism genes.

d

The PSMG1 gene was previously described as DSCR2.